Eye Doctors in Erie, CO
Sparkle in style and see clearly with Erie's newest jewel: Pearle Vision! ✨ Ditch blurry blues and step into a world of designer clarity at the grand opening of Pearle Vision Erie. Treat your eyes to the crème de la crème of eyewear with major brands like Gucci, Prada, Ray-Ban, Oakley, Maui Jim, Tiffany, Silhouette, Persol, Dolce&Gabbana, Burberry, Nike, and Costa Del Mar. No prescription blues here! We accept most major insurance plans, making your dream shades a reality. Celebrate our arrival with dazzling deals! Get 50% off lenses for your first pair and 50% off both frame and lenses for your second pair! That's double the vision, double the style, at half the price. Don't miss your chance to see Erie in stunning focus and luxurious frames. Visit us today at 2120 Village Vista Drive and let Pearle Vision Erie ignite your inner sparkle!
Store info
2120 Village Vista Drive, Erie, CO 80516
- 303-418-8427
Store Hours
| Sun | Closed |
| Mon | 10:00 AM - 6:00 PM |
| Tue | 10:00 AM - 6:00 PM |
| Wed | 10:00 AM - 6:00 PM |
| Thu | 10:00 AM - 6:00 PM |
| Fri | 10:00 AM - 6:00 PM |
| Sat | 9:00 AM - 5:00 PM |
Accepted Insurances
We work with most major health and vision plans.
40% off lenses with frame purchase
Print or show in store to redeem.
Save 40% on lenses with frame purchase. Complete pair (frame and lenses) purchase required. Valid prescription required.
Terms & conditions apply

40% off second pair
Print or show in store to redeem.
Buy a complete pair of eyeglasses or prescription sunglasses (frame and lenses) and get a second pair (same prescription, same day) for up to 40% off.
Terms & conditions applyLearn More
Where to Buy Glasses
Discover MoreHow to Choose an Eye Doctor
Discover MoreHow to Tell if Your Child Needs Glasses
Discover MoreDiscover New Styles
ESSILOR® STELLEST® LENSES
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6-12 years at initiation of treatment.

















